Withdrawal: Makena
Apr. 2023Pharmacy Updates
On March 7, 2023, Covis Pharma announced that it is withdrawing Makena (hydroxyprogesterone caproate injection; also referred to as 17-OHPC) from the market. This drug is used to reduce the risk of preterm birth in women who are pregnant with one baby and have a history of spontaneous preterm birth. Read more about the Makena withdrawal.
Recent Announcements
Watch for a chance to rate your experience with UPMC Health Plan
Watch for a chance to rate your experience with UPMC Health Plan. You may be randomly selected to participate in a 2026 Press Ganey provider satisfaction survey that will begin this month.Aug. 2026Important Notices
Voluntary nationwide recall: Cetirizine (Unique – July)
Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is recalling four lots (GY825029, GY825030, GY825031, GY825032) of Cetirizine Hydrochloride Tablets USP 5 mg. Cetirizine is used for the relief of allergy symptoms, including itchy, red, watery eyes and itchy skin.Jul. 2026Pharmacy Updates
August 2026 UPMC for You and UPMC Community HealthChoices Formulary Updates
Effective Aug. 15, 2026, UPMC for You and UPMC Community HealthChoices are updating their formularies.Jul. 2026Pharmacy Updates